Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taylor-Wharton is a cryogenic equipment manufacturer supplying storage, transportation, regasification, and related cold-chain systems for industrial gas, life sciences, healthcare, and LNG applications. In healthcare and life sciences, its legacy product lines have included liquid nitrogen freezers, dewars, shippers, and other cryogenic storage systems used in biomedical research, biobanking, IVF, pharmaceutical, and biotechnology settings. The company today appears to operate primarily as a commercial equipment business rather than a therapeutics developer, with a broader focus spanning industrial gas infrastructure and hydrogen/liquefied gas systems. Taylor-Wharton is part of the Air Water group and has highlighted hydrogen infrastructure partnerships and product offerings alongside its traditional cryogenic vessel portfolio. Historically, its cryoscience/life sciences business was carved out and later became part of IC Biomedical through Worthington's Life Sciences business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taylor-Wharton International.